Cullinan Therapeutics annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Cullinan Therapeutics Capital Expenditures (CapEx) Growth & History (CGEM)
Cullinan Therapeutics's capital expenditures (capex) was $49,000 for fiscal 2025.
View full Cullinan Therapeutics company overviewCullinan Therapeutics annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $49,000 | $49,000 | — |
| 2024 | 2024-12-31 | $0 | −$208,000 | — |
| 2023 | 2023-12-31 | $208,000 | −$925,000 | −81.64% |
| 2022 | 2022-12-31 | $1.1M | $1.1M | — |
| 2021 | 2021-12-31 | $0 | −$10,000 | — |
| 2020 | 2020-12-31 | $10,000 | — | — |
Cullinan Therapeutics quarterly capital expenditures (capex)
Q1.20
Q2.20
Q3.20
Q4.20
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q4.25
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | $11,000 | $11,000 | — |
| Q4 2024 | 2024-12-31 | $0 | $0 | — |
| Q3 2024 | 2024-09-30 | $0 | $0 | — |
| Q2 2024 | 2024-06-30 | $0 | −$49,000 | — |
| Q1 2024 | 2024-03-31 | $0 | −$159,000 | — |
| Q4 2023 | 2023-12-31 | $0 | −$882,000 | — |
| Q3 2023 | 2023-09-30 | $0 | −$251,000 | — |
| Q2 2023 | 2023-06-30 | $49,000 | $49,000 | — |
| Q1 2023 | 2023-03-31 | $159,000 | $159,000 | — |
| Q4 2022 | 2022-12-31 | $882,000 | — | — |
| Q3 2022 | 2022-09-30 | $251,000 | — | — |
| Q2 2022 | 2022-06-30 | $0 | — | — |
| Q1 2022 | 2022-03-31 | $0 | — | — |
| Q4 2020 | 2020-12-31 | $1,000 | — | — |
| Q3 2020 | 2020-09-30 | $4,000 | — | — |
| Q2 2020 | 2020-06-30 | $4,000 | — | — |
| Q1 2020 | 2020-03-31 | $3,000 | — | — |
Cullinan Therapeutics capital expenditures (capex) trends
Over the last five fiscal years, Cullinan Therapeutics's capital expenditures (capex) increased from $10,000 to $49,000, a change of $39,000. The latest reported quarter, Q4 2025, shows $11,000.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cullinan Therapeutics source filings ↗